Patent details

EP1121129 Title: METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS

Basic Information

Publication number:
EP1121129
PCT Application Number:
PCT/US/1999/020946
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP999514383
PCT Publication Number:
WO/2000/015229
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS
French Title of Invention:
PROCEDE DE TRAITEMENT DE DIABETES A L'AIDE DE L'INHIBITEUR AP2 ET COMBINAISON ASSOCIEE
German Title of Invention:
METHODE ZUR BEHANDLUNG VON DIABETES DIE EINEN AP2-INHIBITOR UND DAZUGEHÖRIGE KOMBINATIONEN VERWENDET
SPC Number:

Dates

Filing date:
13/09/1999
Grant date:
03/09/2008
EP Publication Date:
03/09/2008
PCT Publication Date:
23/03/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/08/2001
EP B1 Publication Date:
03/09/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
13/09/2019
Renunciation date:
Revocation date:
13/09/2008
Annulment date:

Owner

From:
13/09/1999
 
 

Name:
Bristol-Myers Squibb Company
Address:
P.O. Box 4000, Princeton, NJ 08543-4000, United States (US)

Inventor

1

Name:
KODUKULA Krishna
Address:
United States (US)

2

Name:
JACOBSON Bruce, L.
Address:
United States (US)

3

Name:
ROBL Jeffrey, A.
Address:
United States (US)

4

Name:
PARKER Rex, A.
Address:
United States (US)

5

Name:
BILLER Scott, A.
Address:
United States (US)

6

Name:
JAMIL Haris
Address:
United States (US)

Priority

Priority Number:
100677 P
Priority Date:
17/09/1998
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/50;
Filing date Document type Number of pages